Kerry Stokes’ Media Executives and Their Interest in Orthocell
Seven West Media shows a notable focus on ASX-listed medtech company Orthocell. Few outside the industry may recognize Orthocell, a Perth-based medtech firm specializing in cell regeneration therapies. Founded in 2007 as a spin-out from the University of Western Australia, the company generally maintains a market capitalization around $300 million.
Over the past year, Orthocell's value has risen by approximately 80%, presenting a solid performance for a small-cap biotech company. Despite this growth, it remains one of many smaller medtech firms listed on the ASX.
"Most people wouldn’t have heard of Orthocell. It’s a Perth-based, ASX-listed medtech that makes cell regeneration therapies."
Subscribing to certain services allows gifting of five articles monthly to others, providing wider access to niche market insights like those involving Orthocell and similar companies.
Summary
Seven West Media's engagement with Orthocell highlights the rising value and interest in smaller medtech companies on the ASX, reflecting broader trends in niche biotechnology markets.
Would you like the summary to be more detailed or concise?